1000576-59-9 Usage
Description
7-BROMO-1-METHYL-1H-INDAZOLE is an organic compound that serves as a key reagent in the synthesis of various pharmaceutical compounds. It is characterized by its unique molecular structure, which includes a bromo and methyl group attached to a 1H-indazole core. 7-BROMO-1-METHYL-1H-INDAZOLE plays a significant role in the development of therapeutic agents for various medical conditions.
Uses
Used in Pharmaceutical Industry:
7-BROMO-1-METHYL-1H-INDAZOLE is used as a reagent for the synthesis of cyclic benzimidazole derivatives. These derivatives function as protein kinase activators, which are crucial in the treatment of type 2 diabetes, hyperglycemia, and other related diseases. By modulating the activity of protein kinases, these benzimidazole derivatives help regulate glucose metabolism and improve insulin sensitivity, offering potential therapeutic benefits for patients suffering from these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1000576-59-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,5,7 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1000576-59:
(9*1)+(8*0)+(7*0)+(6*0)+(5*5)+(4*7)+(3*6)+(2*5)+(1*9)=99
99 % 10 = 9
So 1000576-59-9 is a valid CAS Registry Number.
1000576-59-9Relevant articles and documents
METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS
-
Paragraph 0287-0289, (2020/01/24)
Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.
Indazole derivatives as CRF antagonists
-
Page/Page column 19, (2010/02/07)
This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: wherein R3 is optionally substituted aryl or heteroaryl, R1 and R2 are as defined in
